Optimal vaccination and herd immunity

Stefano Bosi (), Carmen Camacho () and David Desmarchellier
Additional contact information
Stefano Bosi: EPEE - Centre d'Etudes des Politiques Economiques - UEVE - Université d'Évry-Val-d'Essonne - Université Paris-Saclay
Carmen Camacho: PSE - Paris School of Economics - UP1 - Université Paris 1 Panthéon-Sorbonne - ENS-PSL - École normale supérieure - Paris - PSL - Université Paris Sciences et Lettres - EHESS - École des hautes études en sciences sociales - ENPC - École nationale des ponts et chaussées - CNRS - Centre National de la Recherche Scientifique - INRAE - Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement, PJSE - Paris Jourdan Sciences Economiques - UP1 - Université Paris 1 Panthéon-Sorbonne - ENS-PSL - École normale supérieure - Paris - PSL - Université Paris Sciences et Lettres - EHESS - École des hautes études en sciences sociales - ENPC - École nationale des ponts et chaussées - CNRS - Centre National de la Recherche Scientifique - INRAE - Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement
David Desmarchellier: BETA - Bureau d'Économie Théorique et Appliquée - AgroParisTech - UNISTRA - Université de Strasbourg - Université de Haute-Alsace (UHA) - Université de Haute-Alsace (UHA) Mulhouse - Colmar - UL - Université de Lorraine - CNRS - Centre National de la Recherche Scientifique - INRAE - Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement

Post-Print from HAL

Abstract: Herd immunity is a central concept in epidemiology. It refers to a situation where the amount of recovered and immune individuals is high enough to protect susceptibles from contracting the disease. Herd immunity can be obtained naturally when individuals recover from the disease, or artificially after the administration of an appropriate vaccine. The present paper addresses the question of the amount of public spending in medical research to obtain a vaccine which maximizes welfare. Public spending is assumed to reduce the waiting time to discover a vaccine against an infectious disease evolving according to a SIR model. Both linear and logarithmic preferences are considered with and without time discounting. Worth to note, we show that if an economy has a sufficiently performing technology, then the government should invest as much as the initial public budget allows.

Keywords: COVID-19; Pandemic; Public spending; SIR model (search for similar items in EconPapers)
Date: 2020-08-03
References: Add references at CitEc
Citations:

Published in Covid Economics Papers, 2020, 41, pp.1-27

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
Working Paper: Optimal vaccination and herd immunity (2020)
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:hal:journl:halshs-03231039

Access Statistics for this paper

More papers in Post-Print from HAL
Bibliographic data for series maintained by CCSD ().